DA-2802

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-2802, covering 2017-04-12 to 2021-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients [Phase 3]